Past studies have shown that in diabetics, reduced insulin levels lead to a disorder in insulin signaling, excessive deposition of hyperphosphorylated tau, and ultimately atrophy of the hippocampus and parahippocampal region, resulting in a series of clinical symptoms (Adachi et al., 2021). This evidence concerns the gene MAPT and diabetes mellitus.